Evidence map›Paper›PMID 41883731›Full record

ArticleOphthalmology science2026

Improving Fairness and Mitigating Bias in Multicenter Electronic Health Records Models to Predict Glaucoma Outcomes.

Yihan Zhao, Rohith Ravindranath, Tina Hernandez-Boussard, Joshua D Stein, Sophia Y Wang, SOURCE Consortium

Abstract read
In one paragraph

Article in Ophthalmology science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yihan ZhaoDepartment of Biomedical Data Science, Stanford University, Palo Alto, California.
Rohith RavindranathDepartment of Ophthalmology, Byers Eye Institute, Stanford University, Palo Alto, California.
Tina Hernandez-BoussardCenter for Biomedical Informatics Research, Stanford University, Palo Alto, California.
Joshua D SteinKellogg Eye Center, Department of Ophthalmology, University of Michigan, Ann Arbor, Michigan.
Sophia Y WangDepartment of Ophthalmology, Byers Eye Institute, Stanford University, Palo Alto, California.
SOURCE Consortium

Funding

Improving Generalizability in Artificial Intelligence Algorithms for GlaucomaR01EY036893 · NEI · STANFORD UNIVERSITY · PI Sophia Ying Wang · 2025 to 2026
$1.3M
NEI NIH HHS R01 EY036893
6 · The paper itself

Abstract

Purpose: To evaluate the effectiveness and generalizability of bias mitigation methods in glaucoma progression prediction models across a multicenter electronic health records (EHRs) repository and to propose a novel evaluation metric that balances performance and fairness in clinical artificial intelligence (AI). Design: A cohort study. Participants: A total of 50 656 glaucoma patients drawn from seven participating institutions in the SOURCE consortium, a harmonized EHR repository spanning ophthalmology departments in the United States. Methods: We trained five model architectures (e.g., XGBoost, neural networks, and transformers) to predict progression to surgery. Each model was evaluated with and without five bias-mitigation methods across preprocessing, inprocessing, and postprocessing. Performance and fairness were assessed on 1 internal and 2 external test sets. We introduced FairOdds-AUC, a composite metric that adjusts area under the receiver operating curve (AUROC) by equalized odds gaps across sex and race/ethnicity. The FairOdds-AUC metric was implemented in Python and is available as an open-source package for reproducibility and future use. Main Outcome Measures: Area under the receiver operating curve, equalized odds for sex and race/ethnicity, and FairOdds-AUC. Results: Inprocessing methods, particularly inverse propensity weighting (IPW) and the adversarial fairness classifier, achieved more favorable fairness-performance tradeoffs than baseline and other mitigation approaches across all evaluation sets. For example, on the internal test set, IPW improved FairOdds-AUC from 0.562 (95% confidence interval 0.540, 0.581) to 0.600 (0.575, 0.629) for the transformer model and from 0.556 (0.534, 0.577) to 0.5922 (0.53, 0.61919) for a fully connected network, while maintaining essentially the same discrimination. Adversarial fairness classifier achieved the highest FairOdds-AUC in several settings (up to 0.613 [0.595, 0.629] for the deep learning fully connected network) with substantial reductions in equalized odds difference for sex. Postprocessing and preprocessing bias mitigation strategies yielded more variable FairOdds-AUC changes (-0.009 to +0.021) and showed weaker generalizability across external sites. FairOdds-AUC consistently reflected the balance between AUROC and equalized odds, with the optimal mitigation strategy depending on fairness-utility priorities. Conclusions: Across a large, diverse glaucoma cohort, inprocessing bias methods provided the most consistent performance across evaluation sites in promoting fairness. FairOdds-AUC offers a flexible, interpretable way to evaluate clinical AI where fairness matters. Our findings support the recommendation to incorporate fairness evaluations and fairness-aware model training for future ophthalmic AI applications. Financial Disclosures: Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.

Indexed as

Artificial intelligenceElectronic health recordsFairnessGeneralizabilityGlaucoma

Identifiers

PMID41883731
PMCPMC13011205

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.